Matthias A. Clauss, PhD
Senior Research Professor of Medicine
Address
R3 C400
PULM
Indianapolis, IN
PULM
Indianapolis, IN
Bio
Matthias Clauss was born and raised close to Munich, Germany. He completed his undergraduate and master training in chemistry at the University in Ulm, Germany. After having received his PhD from the University of Heidelberg in cancer research, he completed his postdoctoral research at the Columbia University in New York. After intermittent activities at Max-Planck-Institutes in Germany, he joined the Indiana University School Medicine as faculty.
Matthias Clauss is dedicated to biomedical research and aims to elucidate the role of aging, viral infections and chronic inflammation in cardiovascular and pulmonary diseases, holds four US patents and is co-founder of several start up companies, which aim to treat COPD/emphysema, pulmonary hypertension, acute lung injury and to eradicate latent HIV infection.
Titles & Appointments
- Senior Research Professor of Medicine
- Senior Research Professor of Anatomy, Cell Biology & Physiology
- Senior Research Professor of Microbiology & Immunology
-
Education1991 FEL Postdoctoral Fellowship, Columbia University1988 PhD University of Heidelberg
-
PublicationsTACE/ADAM17 substrates associate with ACS (Ep-CAM, HB-EGF) and follow-up MACE (TNFR1 and TNFR2)
Melody Chemaly, Roisin McAllister, Aaron Peace, Anthony John Bjourson, Steve Watterson, Andrew Parton, Matthias Clauss, Victoria McGilligan Atherosclerosis Plus December 2022Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension.
Rodriguez-Irizarry VJ; Schneider AC; Ahle D; Smith JM; Suarez-Martinez EB; Salazar EA; McDaniel Mims B; Rasha F; Moussa H; Moustaïd-Moussa N; Pruitt K; Fonseca M; Henriquez M; Clauss MA; Grisham MB; Almodovar S; Frontiers in immunology 2022 Aug 5Impact of human immunodeficiency virus on pulmonary vascular disease.
Kumar A; Mahajan A; Salazar EA; Pruitt K; Guzman CA; Clauss MA; Almodovar S; Dhillon NK; Global cardiology science & practice 2021 Jun 30Viral Bad News Sent by EVAIL.
Clauss M; Chelvanambi S; Cook C; ElMergawy R; Dhillon N; Viruses 2021 Jun 18Extracellular vesicles: novel communicators in lung diseases.
Mohan A; Agarwal S; Clauss M; Britt NS; Dhillon NK; Respiratory research 2020 Jul 8Clonally selected primitive endothelial cells promote occlusive pulmonary arteriopathy and severe pulmonary hypertension in rats exposed to chronic hypoxia.
Bhagwani AR; Farkas D; Harmon B; Authelet KJ; Cool CD; Kolb M; Goncharova E; Yoder MC; Clauss M; Freishtat R; Farkas L; Scientific reports 2020 Jan 24The TNF-derived TIP peptide activates the epithelial sodium channel and ameliorates experimental nephrotoxic serum nephritis.
Madaio MP; Czikora I; Kvirkvelia N; McMenamin M; Yue Q; Liu T; Toque HA; Sridhar S; Covington K; Alaisami R; O'Connor PM; Caldwell RW; Chen JK; Clauss M; Brands MW; Eaton DC; Romero MJ; Lucas R; Kidney international 2019 Mar 21HIV-Nef Protein Persists in the Lungs of Aviremic Patients with HIV and Induces Endothelial Cell Death.
Chelvanambi S; Bogatcheva NV; Bednorz M; Agarwal S; Maier B; Alves NJ; Li W; Syed F; Saber MM; Dahl N; Lu H; Day RB; Smith P; Jolicoeur P; Yu Q; Dhillon NK; Weissmann N; Twigg Iii HL; Clauss M; 2019 MarDysfunctional stem and progenitor cells impair fracture healing with age.
Wagner DR; Karnik S; Gunderson ZJ; Nielsen JJ; Fennimore A; Promer HJ; Lowery JW; Loghmani MT; Low PS; McKinley TO; Kacena MA; Clauss M; Li J; World journal of stem cells 2019 Jun 26Subcutaneous administration of neutralizing antibodies to endothelial monocyte-activating protein II attenuates cigarette smoke-induced lung injury in mice.
Koike K; Beatman EL; Schweitzer KS; Justice MJ; Mikosz AM; Ni K; Clauss MA; Petrache I; American journal of physiology. Lung cellular and molecular physiology 2019 Jan 10HIV-Nef Protein Transfer to Endothelial Cells Requires Rac1 Activation and Leads to Endothelial Dysfunction Implications for Statin Treatment in HIV Patients.
Chelvanambi S; Gupta SK; Chen X; Ellis BW; Maier BF; Colbert TM; Kuriakose J; Zorlutuna P; Jolicoeur P; Obukhov AG; Clauss M; Circulation research 2019 Aug 27EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury.
Lu H; Chelvanambi S; Poirier C; Saliba J; March KL; Clauss M; Bogatcheva NV; Molecular therapy : the journal of the American Society of Gene Therapy 2018 Jun 14Critical role of endoplasmic reticulum stress in chronic endothelial activation-induced visual deficits in tie2-tumor necrosis factor mice.
Lenin R; Nagy PG; Alli S; Rao VR; Clauss MA; Kompella UB; Gangaraju R; 2018 Jul 27Acute <i>Moraxella catarrhalis</i> Airway Infection of Chronically Smoke-Exposed Mice Increases Mechanisms of Emphysema Development: A Pilot Study.
Fischer K; Doehn JM; Herr C; Lachner C; Heinrich A; Kershaw O; Voss M; Jacobson MH; Gruber AD; Clauss M; Witzenrath M; Bals R; Gutbier B; Slevogt H; 2018 Dec 11Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events.
Chemaly M; McGilligan V; Gibson M; Clauss M; Watterson S; Alexander HD; Bjourson AJ; Peace A; Archives of cardiovascular diseases 2017 Oct 31A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
Gupta SK; Kamendulis LM; Clauss MA; Liu Z; AIDS (London, England) 2016 Sep 24A pilot trial of pentoxifylline on endothelial function and inflammation in HIV-infected patients initiating antiretroviral therapy.
Gupta SK; Dubé MP; Stein JH; Clauss MA; Liu Z; AIDS (London, England) 2016 Aug 24Endogenous Transmembrane TNF-Alpha Protects Against Premature Senescence in Endothelial Colony Forming Cells.
Green LA; Njoku V; Mund J; Case J; Yoder M; Murphy MP; Clauss M; Circulation research 2016 Apr 13Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.
Wang T; Yi R; Green LA; Chelvanambi S; Seimetz M; Clauss M; Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2015 Jul 9Intracellular Nef detected in peripheral blood mononuclear cells from HIV patients.
Wang T; Green LA; Gupta SK; Amet T; Byrd DJ; Yu Q; Twigg HL 3rd; Clauss M; AIDS research and human retroviruses 2014 Sep 4Evaluating membrane affinity by integrating protein orientations.
Zhu F; Clauss M; Journal of molecular graphics & modelling 2014 Oct 29Transfer of intracellular HIV Nef to endothelium causes endothelial dysfunction.
Wang T; Green LA; Gupta SK; Kim C; Wang L; Almodovar S; Flores SC; Prudovsky IA; Jolicoeur P; Liu Z; Clauss M; PloS one 2014 Mar 7HIV Tat protein affects circadian rhythmicity by interfering with the circadian system.
Wang T; Jiang Z; Hou W; Li Z; Cheng S; Green LA; Wang Y; Wen X; Cai L; Clauss M; Wang Z; HIV medicine 2014 Apr 20HIV envelope protein gp120-induced apoptosis in lung microvascular endothelial cells by concerted upregulation of EMAP II and its receptor, CXCR3.
Green LA; Yi R; Petrusca D; Wang T; Elghouche A; Gupta SK; Petrache I; Clauss M; 2013 Dec 6Pentoxifylline, inflammation, and endothelial function in HIV-infected persons: a randomized, placebo-controlled trial.
Gupta SK; Mi D; Dubé MP; Saha CK; Johnson RM; Stein JH; Clauss MA; Mather KJ; Desta Z; Liu Z; PloS one 2013 Apr 9Pentoxifylline reduces tumor necrosis factor-a and HIV-induced vascular endothelial activation.
Green LA; Kim C; Gupta SK; Rajashekhar G; Rehman J; Clauss M; AIDS research and human retroviruses 2012 May 8Cigarette smoke-induced CXCR3 receptor up-regulation mediates endothelial apoptosis.
Green LA; Petrusca D; Rajashekhar G; Gianaris T; Schweitzer KS; Wang L; Justice MJ; Petrache I; Clauss M; American journal of respiratory cell and molecular biology 2012 Aug 30Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice.
Rajashekhar G; Gupta A; Marin A; Friedrich J; Willuweit A; Berg DT; Cramer MS; Sandusky GE; Sutton TA; Basile DP; Grinnell BW; Clauss M; American journal of physiology. Renal physiology 2011 Nov 30Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in mice.
Clauss M; Voswinckel R; Rajashekhar G; Sigua NL; Fehrenbach H; Rush NI; Schweitzer KS; Yildirim AÖ; Kamocki K; Fisher AJ; Gu Y; Safadi B; Nikam S; Hubbard WC; Tuder RM; Twigg HL 3rd; Presson RG; Sethi S; Petrache I; The Journal of clinical investigation 2011 May 16Pro-inflammatory angiogenesis is mediated by p38 MAP kinase.
Rajashekhar G; Kamocka M; Marin A; Suckow MA; Wolter WR; Badve S; Sanjeevaiah AR; Pumiglia K; Rosen E; Clauss M; Journal of cellular physiology 2011 MarAbacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cells.
Kim C; Gupta SK; Green L; Taylor BM; Deuter-Reinhard M; Desta Z; Clauss M; Antiviral therapy 2011Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: a pilot study.
Gupta SK; Johnson RM; Mather KJ; Clauss M; Rehman J; Saha C; Desta Z; Dubé MP; AIDS (London, England) 2010 Jun 1Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway.
Zhang Y; Herbert BS; Rajashekhar G; Ingram DA; Yoder MC; Clauss M; Rehman J; FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009 Jan 5A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro.
Rajashekhar G; Mitnacht-Kraus R; Ispe U; Garrison J; Hou Y; Taylor B; Petrache I; Vestweber D; Clauss M; Journal of immunological methods 2009 Aug 14Differences in the temporal expression of regulatory growth factors during choroidal neovascular development.
Hu W; Criswell MH; Fong SL; Temm CJ; Rajashekhar G; Cornell TL; Clauss MA; Experimental eye research 2008 Nov 1Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation.
Fernandez L; Rodriguez S; Huang H; Chora A; Fernandes J; Mumaw C; Cruz E; Pollok K; Cristina F; Price JE; Ferkowicz MJ; Scadden DT; Clauss M; Cardoso AA; Carlesso N; Experimental hematology 2008 MayIFATS collection: Adipose stromal cell differentiation is reduced by endothelial cell contact and paracrine communication: role of canonical Wnt signaling.
Rajashekhar G; Traktuev DO; Roell WC; Johnstone BH; Merfeld-Clauss S; Van Natta B; Rosen ED; March KL; Clauss M; Stem cells (Dayton, Ohio) 2008 Jul 31EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury.
Nührenberg TG; Langwieser N; Schwarz JB; Hou Y; Frank P; Sorge F; Matschurat S; Seidl S; Kastrati A; Schömig A; Clauss MA; Zohlnhöfer D; Cardiovascular research 2007 Nov 20Divergent and convergent effects on gene expression and function in acute versus chronic endothelial activation.
Rajashekhar G; Grow M; Willuweit A; Patterson CE; Clauss M; Physiological genomics 2007 Jun 12Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth.
Lucerna M; Pomyje J; Mechtcheriakova D; Kadl A; Gruber F; Bilban M; Sobanov Y; Schabbauer G; Breuss J; Wagner O; Bischoff M; Clauss M; Binder BR; Hofer E; Cancer research 2006 Jul 1Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation.
Rajashekhar G; Willuweit A; Patterson CE; Sun P; Hilbig A; Breier G; Helisch A; Clauss M; Journal of vascular research 2006 Jan 12Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3.
Hou Y; Plett PA; Ingram DA; Rajashekhar G; Orschell CM; Yoder MC; March KL; Clauss M; Experimental hematology 2006 AugInhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants.
Heidenreich R; Machein M; Nicolaus A; Hilbig A; Wild C; Clauss M; Plate KH; Breier G; International journal of cancer 2004 Sep 1Endothelial monocyte-activating polypeptide II causes NOS-dependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine.
Tsai BM; Wang M; Clauss M; Sun P; Meldrum DR; American journal of physiology. Regulatory, integrative and comparative physiology 2004 May 20Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties.
Zohlnhöfer D; Nührenberg TG; Neumann FJ; Richter T; May AE; Schmidt R; Denker K; Clauss MA; Schömig A; Baeuerle PA; Molecular pharmacology 2004 AprNegative regulatory role of PI3-kinase in TNF-induced tumor necrosis.
Matschurat S; Blum S; Mitnacht-Kraus R; Dijkman HB; Kanal L; De Waal RM; Clauss M; International journal of cancer 2003 Oct 20An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.
Koczulla R; von Degenfeld G; Kupatt C; Krötz F; Zahler S; Gloe T; Issbrücker K; Unterberger P; Zaiou M; Lebherz C; Karl A; Raake P; Pfosser A; Boekstegers P; Welsch U; Hiemstra PS; Vogelmeier C; Gallo RL; Clauss M; Bals R; The Journal of clinical investigation 2003 JunCirculating vascular progenitor cells do not contribute to compensatory lung growth.
Voswinckel R; Ziegelhoeffer T; Heil M; Kostin S; Breier G; Mehling T; Haberberger R; Clauss M; Gaumann A; Schaper W; Seeger W; Circulation research 2003 Jul 24VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.
Pipp F; Heil M; Issbrücker K; Ziegelhoeffer T; Martin S; van den Heuvel J; Weich H; Fernandez B; Golomb G; Carmeliet P; Schaper W; Clauss M; Circulation research 2003 Jan 23Regulation of EMAP II by hypoxia.
Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M; The American journal of pathology 2003 JanAn engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
Heil M; Mitnacht-Krauss R; Issbrücker K; van den Heuvel J; Dehio C; Schaper W; Clauss M; Weich HA; Angiogenesis 2003Dissection of monocyte and endothelial activities by using VEGF-receptor specific ligands.
Clauss M; Pipp F; Issbrücker K; Weich H; Heil M; Schaper W; Advances in experimental medicine and biology 2003NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells.
Lucerna M; Mechtcheriakova D; Kadl A; Schabbauer G; Schäfer R; Gruber F; Koshelnick Y; Müller HD; Issbrücker K; Clauss M; Binder BR; Hofer E; The Journal of biological chemistry 2002 Nov 8p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.
Issbrücker K; Marti HH; Hippenstiel S; Springmann G; Voswinckel R; Gaumann A; Breier G; Drexler HC; Suttorp N; Clauss M; FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002 Dec 18Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1.
Leenders W; Lubsen N; van Altena M; Clauss M; Deckers M; Löwik C; Breier G; Ruiter D; de Waal R; Laboratory investigation; a journal of technical methods and pathology 2002 AprChronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells.
Willuweit A; Sass G; Schöneberg A; Eisel U; Tiegs G; Clauss M; Journal of immunology (Baltimore, Md. : 1950) 2001 Oct 1Upregulation of TRAF-3 by shear stress blocks CD40-mediated endothelial activation.
Urbich C; Mallat Z; Tedgui A; Clauss M; Zeiher AM; Dimmeler S; The Journal of clinical investigation 2001 NovA permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability.
Clauss M; Sunderkötter C; Sveinbjörnsson B; Hippenstiel S; Willuweit A; Marino M; Haas E; Seljelid R; Scheurich P; Suttorp N; Grell M; Risau W; Blood 2001 Mar 1An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression.
Blum S; Issbrüker K; Willuweit A; Hehlgans S; Lucerna M; Mechtcheriakova D; Walsh K; von der Ahe D; Hofer E; Clauss M; The Journal of biological chemistry 2001 Jul 9Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
Mechtcheriakova D; Schabbauer G; Lucerna M; Clauss M; De Martin R; Binder BR; Hofer E; FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001 JanThe EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component.
Shalak V; Kaminska M; Mitnacht-Kraus R; Vandenabeele P; Clauss M; Mirande M; The Journal of biological chemistry 2001 Apr 16Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression.
Heil M; Clauss M; Suzuki K; Buschmann IR; Willuweit A; Fischer S; Schaper W; European journal of cell biology 2000 NovThe endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7.
Behrensdorf HA; van de Craen M; Knies UE; Vandenabeele P; Clauss M; FEBS letters 2000 Jan 21Vascular endothelial growth factor: A Jack-of-all-trades or a nonspecific stress gene?
Clauss M; Schaper W; Circulation research 2000 Feb 18Expression of EMAP II in the developing and adult mouse.
Knies UE; Kröger S; Clauss M; Apoptosis : an international journal on programmed cell death 2000 AprMolecular biology of the VEGF and the VEGF receptor family.
Clauss M; Seminars in thrombosis and hemostasis 2000Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation.
Daemen MA; van 't Veer C; Denecker G; Heemskerk VH; Wolfs TG; Clauss M; Vandenabeele P; Buurman WA; The Journal of clinical investigation 1999 SepA novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C; The EMBO journal 1999 Jan 15Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.
Fischer S; Clauss M; Wiesnet M; Renz D; Schaper W; Karliczek GF; The American journal of physiology 1999 AprRegulation of endothelial monocyte-activating polypeptide II release by apoptosis.
Knies UE; Behrensdorf HA; Mitchell CA; Deutsch U; Risau W; Drexler HC; Clauss M; Proceedings of the National Academy of Sciences of the United States of America 1998 Oct 13VEGF induces hyperpermeability by a direct action on endothelial cells.
Hippenstiel S; Krüll M; Ikemann A; Risau W; Clauss M; Suttorp N; The American journal of physiology 1998 MayFunctions of the VEGF receptor-1 (FLT-1) in the vasculature.
Clauss M; Trends in cardiovascular medicine 1998 AugSynergistic induction of endothelial tissue factor by tumor necrosis factor and vascular endothelial growth factor: functional analysis of the tumor necrosis factor receptors.
Clauss M; Grell M; Fangmann C; Fiers W; Scheurich P; Risau W; FEBS letters 1996 Jul 29The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.
Clauss M; Weich H; Breier G; Knies U; Röckl W; Waltenberger J; Risau W; The Journal of biological chemistry 1996 Jul 26Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W; Developmental dynamics : an official publication of the American Association of Anatomists 1995 NovHypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells.
Kuwabara K; Ogawa S; Matsumoto M; Koga S; Clauss M; Pinsky DJ; Lyn P; Leavy J; Witte L; Joseph-Silverstein J; Proceedings of the National Academy of Sciences of the United States of America 1995 May 9The non-receptor tyrosine kinase Lyn is localised in the developing murine blood-brain barrier.
Achen MG; Clauss M; Schnürch H; Risau W; Differentiation; research in biological diversity 1995 JulA peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
Kao J; Fan YG; Haehnel I; Brett J; Greenberg S; Clauss M; Kayton M; Houck K; Kisiel W; Seljelid R; The Journal of biological chemistry 1994 Apr 1Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
Shen H; Clauss M; Ryan J; Schmidt AM; Tijburg P; Borden L; Connolly D; Stern D; Kao J; Blood 1993 May 15Relevance of tumour necrosis factor-alpha and interleukin-1-alpha in the pathogenesis of hypoxia-related organ failure.
Gerlach H; Gerlach M; Clauss M; European journal of anaesthesiology 1993 JulEndothelial-monocyte activating polypeptides (EMAPs): tumor derived mediators which activate the host inflammatory response.
Kao J; Fan YG; Haehnel I; Clauss M; Stern D; Behring Institute Mitteilungen 1993 AugIsolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface.
Schmidt AM; Vianna M; Gerlach M; Brett J; Ryan J; Kao J; Esposito C; Hegarty H; Hurley W; Clauss M; The Journal of biological chemistry 1992 Jul 25Selective induction of endothelial cell tissue factor in the presence of a tumour-derived mediator: a potential mechanism of flavone acetic acid action in tumour vasculature.
Murray JC; Clauss M; Denekamp J; Stern D; International journal of cancer 1991 Sep 9Hypoxia induces endothelial cell synthesis of membrane-associated proteins.
Ogawa S; Clauss M; Kuwabara K; Shreeniwas R; Butura C; Koga S; Stern D; Proceedings of the National Academy of Sciences of the United States of America 1991 Nov 1Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D; The Journal of experimental medicine 1990 Dec 1The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function.
Ogawa S; Shreeniwas R; Brett J; Clauss M; Furie M; Stern DM; British journal of haematology 1990 AugA polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin.
Clauss M; Murray JC; Vianna M; de Waal R; Thurston G; Nawroth P; Gerlach H; Bach R; Familletti PC; Stern D; The Journal of biological chemistry 1990 Apr 25
Research Labs
Faculty research at IU School of Medicine is transforming health. Details about the medical research being conducted in faculty labs throughout IU School of Medicine are available in the Research section of this site.